-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
New Israeli study: Inoculation of new crown vaccine booster significantly reduces the risk of infection |
Xinhua News Agency, Beijing, September 7 (Reporter Zhang Ying) Two preprinted research papers recently published by Israeli researchers show that the third dose of Pfizer's new crown vaccine can significantly reduce the risk of new crown virus infection
.
Israel began to carry out the new crown vaccine booster vaccination in phases from mid-July, mainly using Pfizer vaccine
.
The country began to vaccinate the third dose of vaccine for adults with cancer or have had an organ transplant operation and other immune system damage from July 12, and from July 30 for the third dose of vaccine for people over 60 years old, until August On the 29th, the scope of the third dose of vaccination has been extended to people over 12 years of age
The first study on the effect of the booster vaccine was completed by the Israeli Ministry of Health and the Israeli Weizmann Institute of Science and other research institutions
.
Between July 30 and August 22, the researchers followed up about 1.
The second study is a collaboration between Israel Maccabi Healthcare Services Company and Yale University in the United States
.
In order to evaluate the effectiveness of vaccination to prevent new crown infections, the researchers used patient data from Maccabi Healthcare Services to conduct a preliminary retrospective study
Both of the above-mentioned preprinted papers have been published on the Medical Paper Archives website
.
The US "Science" magazine website recently quoted David Dowdy, an epidemiologist at Johns Hopkins University in the United States, and reported that if the goal is to provide a high level of short-term immunity, vaccination is undoubtedly a Good way
Focus on the new crown pneumonia epidemic